Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

In line with guidelines recommending genetic testing for diagnosis of kidney diseases, studies show improved diagnosis and management based on results. Genetic testing for kidney diseases leads to a ...

It takes years for most people with a rare disease to learn what is ailing them. Their symptoms may be crystal clear, but the cause isn’t. Efforts by the Department of Justice — an agency not known ...

At Children's Hospital Colorado, Aurora, Colorado, pediatricians will soon have a new ally in diagnosing and identifying complex neurodevelopmental conditions like ...

An analysis of DNA from millions of individuals has identified shared genetic pathways across psychiatric disorders, findings ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service ...

Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...

A new study has provided new insights into the the genetic overlap among some psychiatric disorders, and can help explain why ...

Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has signed an agreement with ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks.The service increases ...

Ahmedabad-based Zydus Lifesciences Ltd has inked a pact with precision diagnostics company Myriad Genetics from the USA to introduce globally validated cancer-risk assessment and prognostic tests in ...